top of page
  • Writer's pictureARQon

Europe - May 2017

  • Europe: European Parliament adopts new medical devices and in vitro diagnostics Regulations

  • Europe: Court of Justice delivers its judgment on PIP breast implants case

  • Europe: Proposed updates to Common Technical Specifications for certain IVDs

  • Europe: SCHEER issues preliminary Opinion on use of non-human primates in biomedical research, production and testing of products and devices

  • Finland: Markus Henriksson appointed to lead Valvira

  • France: New obligations for Class III and implantable medical device manufacturers

  • Ireland: Draft guide to Good Distribution Practice for medical devices and in vitro diagnostics

  • Switzerland: New restrictions proposed for elemental mercury and mercury compounds, including use in dental amalgam

  • UK: Significant fee increases introduced by MHRA to aid cost recovery

  • UK: MHRA updates guidance on the regulations affecting medical devices and how the Agency enforces them

  • UK: Virtual manufacturing replaces own brand labelling

Click here for the full article on Global Regulatory Press.

Contact us at info@arq-on.com.


28 views0 comments

Recent Posts

See All

Europe - May 2020

Denmark: New rules mean non-serious adverse events may also need to be reported EU: Application of Regulation (EU) 2017/745 postponed by one year EU: Continued use of lead as a thermal stabiliser in P

EU: MDR delayed to 26 May 2021

Application of the Medical Devices Regulation (MDR) has been deferred by one year, until 26 May 2021, for fear of shortage or delay in getting essential medical devices needed to combat Covid-19. The

EU 2020 MDR Guidance Notes For Class I Manufacturers

There will be no transition period for Class I medical devices which remain in Class I under MDR. From 26th May 2020 onwards, the conformity for Class I medical devices which are not subject to up-cla

bottom of page